160 related articles for article (PubMed ID: 29792394)
21. Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients.
Suzuki H; Kanno Y;
Hypertens Res; 2005 Apr; 28(4):307-14. PubMed ID: 16138560
[TBL] [Abstract][Full Text] [Related]
22. Candesartan cilexetil: in children and adolescents aged 1 to <17 years with hypertension.
Hoy SM; Keating GM
Am J Cardiovasc Drugs; 2010; 10(5):335-42. PubMed ID: 20860416
[TBL] [Abstract][Full Text] [Related]
23. Candesartan cilexetil: an angiotensin II receptor blocker.
Stoukides CA; McVoy HJ; Kaul AF
Ann Pharmacother; 1999 Dec; 33(12):1287-98. PubMed ID: 10630830
[TBL] [Abstract][Full Text] [Related]
24. Switch from ABCD pretreatment to A-II-A treatment: a multinational, open, centrally randomized, prospective parallel group comparison.
Asmar R; Porcellati C; Dusing R
Drugs Exp Clin Res; 2004; 30(4):153-61. PubMed ID: 15553661
[TBL] [Abstract][Full Text] [Related]
25. Diuretics enhance effects of increased dose of candesartan on ambulatory blood pressure reduction in Japanese patients with uncontrolled hypertension treated with medium-dose angiotensin II receptor blockers.
Sakima A; Kita T; Nakada S; Yokota N; Tamaki N; Etoh T; Shimokubo T; Kitamura K; Takishita S; Ohya Y
Clin Exp Hypertens; 2014; 36(1):40-5. PubMed ID: 23713902
[TBL] [Abstract][Full Text] [Related]
26. Candesartan cilexetil: safety and tolerability in healthy volunteers and patients with hypertension.
Belcher G; Hübner R; George M; Elmfeldt D; Lunde H
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S85-9. PubMed ID: 9331017
[TBL] [Abstract][Full Text] [Related]
27. Effect of combination therapy of benidipine hydrochloride and candesartan cilexetil on serum lipid metabolism and blood pressure in elderly hypertensive patients with type 2 diabetes mellitus.
Sasaki H; Kanai S; Oyama T; Miyashita Y; Yamamura S; Shirai K
J Atheroscler Thromb; 2006 Jun; 13(3):149-57. PubMed ID: 16835470
[TBL] [Abstract][Full Text] [Related]
28. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
Baguet JP; Nisse-Durgeat S; Mouret S; Asmar R; Mallion JM
Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
[TBL] [Abstract][Full Text] [Related]
29. Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age.
Schaefer F; van de Walle J; Zurowska A; Gimpel C; van Hoeck K; Drozdz D; Montini G; Bagdasorova IV; Sorof J; Sugg J; Teng R; Hainer JW;
J Hypertens; 2010 May; 28(5):1083-90. PubMed ID: 20160654
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of candesartan cilexetil in special patient groups.
Trenkwalder P
Blood Press Suppl; 2000; 1():27-30. PubMed ID: 11059633
[TBL] [Abstract][Full Text] [Related]
31. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
32. The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population.
McInnes GT; O'Kane KP; Jonker J; Roth J
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S75-80. PubMed ID: 9331015
[TBL] [Abstract][Full Text] [Related]
33. Candesartan cilexetil: a new, long-acting, effective angiotensin II type 1 receptor blocker.
Sever P
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S91-5. PubMed ID: 9331018
[TBL] [Abstract][Full Text] [Related]
34. The effects of replacing dihydropyridine calcium-channel blockers with angiotensin II receptor blocker on the quality of life of hypertensive patients.
Yamamoto S; Kawashima T; Kunitake T; Koide S; Fujimoto H
Blood Press Suppl; 2003 Dec; 2():22-8. PubMed ID: 14761073
[TBL] [Abstract][Full Text] [Related]
35. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.
Philipp T; Martinez F; Geiger H; Moulin B; Mourad G; Schmieder R; Lièvre M; Heemann U; Legendre C
Nephrol Dial Transplant; 2010 Mar; 25(3):967-76. PubMed ID: 19887503
[TBL] [Abstract][Full Text] [Related]
36. Use of candesartan cilexetil decreases proteinuria in renal transplant patients with chronic allograft dysfunction.
Omoto K; Tanabe K; Tokumoto T; Shimmura H; Ishida H; Toma H
Transplantation; 2003 Oct; 76(8):1170-4. PubMed ID: 14578748
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy with candesartan cilexetil plus hydrochlorothiazide in patients unresponsive to low-dose hydrochlorothiazide.
Plouin PF
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S65-6. PubMed ID: 9331012
[No Abstract] [Full Text] [Related]
38. Effective dose range of candesartan cilexetil for systemic hypertension. Candesartan Cilexetil Study Investigators.
Bell TP; DeQuattro V; Lasseter KC; Ruff D; Hardison JD; Cushing D; Kezer AE; Michelson EL
Am J Cardiol; 1999 Jan; 83(2):272-5, A6. PubMed ID: 10073836
[TBL] [Abstract][Full Text] [Related]
39. Effects of angiotensin II AT1 receptor inhibition and exercise training on insulin action in rats on high-fat diet.
Wang Z; Koike T; Li P; Jiang H; Natsume Y; Mu L; Chen T; Oshida Y
Life Sci; 2012 Feb; 90(9-10):322-7. PubMed ID: 22210187
[TBL] [Abstract][Full Text] [Related]
40. Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years.
Trachtman H; Hainer JW; Sugg J; Teng R; Sorof JM; Radcliffe J;
J Clin Hypertens (Greenwich); 2008 Oct; 10(10):743-50. PubMed ID: 19090875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
